Zobrazeno 1 - 10
of 82
pro vyhledávání: '"Marian S. Macsai"'
Autor:
Andrew B Lassman, Stephanie L Pugh, Tony J C Wang, Kenneth Aldape, Hui K Gan, Matthias Preusser, Michael A Vogelbaum, Erik P Sulman, Minhee Won, Peixin Zhang, Golnaz Moazami, Marian S Macsai, Mark R Gilbert, Earle E Bain, Vincent Blot, Peter J Ansell, Suvajit Samanta, Madan G Kundu, Terri S Armstrong, Jeffrey S Wefel, Clemens Seidel, Filip Y de Vos, Sigmund Hsu, Andrés F Cardona, Giuseppe Lombardi, Dmitry Bentsion, Richard A Peterson, Craig Gedye, Véronique Bourg, Antje Wick, Walter J Curran, Minesh P Mehta
Publikováno v:
Neuro-Oncology. 25:339-350
Background Approximately 50% of newly diagnosed glioblastomas (GBMs) harbor epidermal growth factor receptor gene amplification (EGFR-amp). Preclinical and early-phase clinical data suggested efficacy of depatuxizumab mafodotin (depatux-m), an antibo
Autor:
Clemens Seidel, Matthias Preusser, Antje Wick, Dmitry Bentsion, Minhee Won, Walter J. Curran, Suvajit Samanta, Earle Bain, Giuseppe Lombardi, Andrés F. Cardona, Tony J. C. Wang, Stephanie L. Pugh, Golnaz Moazami, Peter Ansell, Craig Gedye, Marian S. Macsai, Filip de Vos, Peixin Zhang, Mark R. Gilbert, Sigmund Hsu, Kenneth Aldape, Hui K Gan, Vincent Blot, Andrew B. Lassman, Richard A. Peterson, Erik P. Sulman, Madan Gopal Kundu, Minesh P. Mehta, Christine Lebrun-Frenay, Michael A. Vogelbaum
Publikováno v:
Neuro Oncol
BACKGROUND Approximately 50% of nGBMs harbor EGFR-amp. Depatuxizumab mafodotin (depatux-m) is an antibody drug conjugate: a monoclonal antibody that binds activated EGFR (wild-type and EGFRvIII mutant) linked to a microtubule-inhibitor toxin. Pre-cli
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::96fb51b9cf133d6802c7a8c09ee05fd2
https://europepmc.org/articles/PMC6847524/
https://europepmc.org/articles/PMC6847524/
Publikováno v:
Ophthalmology. 124:604-608
Purpose To study the adherence of rheumatologists to the hydroxychloroquine (HCQ) dosing guidelines established by the American Academy of Ophthalmology in 2011 and 2016. Design Retrospective review of electronic medical records (EMRs) in an integrat
Autor:
David D. Verdier, Mark A. Terry, Donna C Drury, George O D Rosenwasser, Sameera M Farazdaghi, Maureen G. Maguire, Kevin W. Ross, Patricia Dahl, Shahzad I. Mian, Mark C. Soper, Jonathan H. Lass, Beth Ann Benetz, Steven P. Dunn, Marian S. Macsai, Robert C OʼBrien, Loretta B Szczotka-Flynn, Michael L. Nordlund, Christopher G. Stoeger, Jeffrey G. Penta, Doyce V Williams, Caroline K. Hoover, Allison R Ayala
Publikováno v:
Cornea
PURPOSE: To identify donor and recipient factors, including eye bank tissue observations, predictive of operative complications in the Cornea Preservation Time Study. METHODS: One thousand three hundred thirty study eyes undergoing Descemet stripping
Autor:
Sewon Kang, Richard L. Gallo, Jerry Tan, Linda Stein Gold, Diane Thiboutot, Zoe Diana Draelos, Marian S. Macsai, Rox Anderson, Richard D. Granstein, Fran E Cook-Bolden
Publikováno v:
Journal of the American Academy of Dermatology. 82(6)
In 2017, a National Rosacea Society Expert Committee developed and published an updated classification of rosacea to reflect current insights into rosacea pathogenesis, pathophysiology, and management. These developments suggest that a multivariate d
Autor:
Marian S. Macsai, Mira Shiloach
Publikováno v:
Cornea. 38(5)
Fuchs corneal dystrophy (FD) is a common cause of endothelial keratoplasty. Recently, a series of FD cases treated with Descemet stripping only (DSO) demonstrated recovery of the central endothelium without transplantation of donor cells. Ripasudil,
Autor:
Christine Lebrun-Frenay, Giuseppe Lombardi, Craig Gedye, Andrew B. Lassman, Madan G. Kundu, Mark R. Gilbert, Andrés F. Cardona, Erik P. Sulman, Clemens Seidel, Peter Ansell, Marian S. Macsai, Matthias Preusser, Hui K Gan, Kenneth Aldape, Sigmund Hsu, Richard A. Peterson, Golnaz Moazami, Jeffrey S. Wefel, Suvajit Samanta, Michael A. Vogelbaum, Stephanie L. Pugh, Yaakov Stern, Antje Wick, Dmitry Bentsion, Minesh P. Mehta, Earle Bain, Filip de Vos, Terri S. Armstrong, Vincent Blot, Walter J. Curran, Tony J. C. Wang, Minhee Won
Publikováno v:
Neuro Oncol
RTOG 3508/AbbVie M13-813/INTELLANCE-1 was a phase 3 trial of depatuximab-mafodotin (depatux-m, formerly ABT-414) that accrued 639 patients with EGFR-amplified newly diagnosed GBM. At the pre-specified interim OS analysis, the futility criteria were m
Autor:
Marian S. Macsai, Jennifer DeMatteo, Christopher G. Stoeger, Sean L. Edelstein, Chi-Hsiung Wang
Publikováno v:
Cornea. 35:917-926
To investigate the incidence of adverse reactions after corneal transplantation, reported to the Eye Bank Association of America.Incidence of adverse reactions from January 1, 2007, to December 31, 2014, was analyzed.Of the 354,930 transplants perfor
Publikováno v:
JAMA Ophthalmology. 138:97